英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

poisoning    音标拼音: [p'ɔɪzənɪŋ]
n. 中毒

中毒

poisoning
n 1: the physiological state produced by a poison or other toxic
substance [synonym: {poisoning}, {toxic condition},
{intoxication}]
2: the act of giving poison to a person or animal with the
intent to kill

Poison \Poi"son\, v. t. [imp. & p. p. {Poisoned}; p. pr. & vb.
n. {Poisoning}.] [Cf. OF. poisonner, F. empoissoner, L.
potionare to give to drink. See {Poison}, n.]
[1913 Webster]
1. To put poison upon or into; to infect with poison; as, to
poison an arrow; to poison food or drink. "The ingredients
of our poisoned chalice." --Shak.
[1913 Webster]

2. To injure or kill by poison; to administer poison to.
[1913 Webster]

If you poison us, do we not die ? --Shak.
[1913 Webster]

3. To taint; to corrupt; to vitiate; as, vice poisons
happiness; slander poisoned his mind.
[1913 Webster]

Whispering tongues can poison truth. --Coleridge.
[1913 Webster]

83 Moby Thesaurus words for "poisoning":
adulteration, autointoxication, bane, befouling, beheading, blood,
blood poisoning, bloodletting, bloodshed, braining, burning,
capital punishment, contamination, corruption, crucifixion,
dealing death, decapitation, decollation, defenestration,
defilement, destruction, destruction of life, dispatch,
electrocution, envenoming, ergotism, euthanasia, execution,
extermination, festering, flow of blood, food poisoning, fouling,
fusillade, garrote, gassing, gore, hanging, hemlock, immolation,
infection, intoxication, judicial murder, kill, killing,
lapidation, martyrdom, martyrization, mercy killing, milk sickness,
misuse, necktie party, perversion, pollution, prostitution,
ptomaine poisoning, pyemia, ritual killing, ritual murder,
sacrifice, sepsis, septic poisoning, septicemia, septicopyemia,
shooting, slaughter, slaying, stoning, strangling, strangulation,
suppuration, taking of life, the ax, the block, the chair,
the gallows, the gas chamber, the guillotine, the hot seat,
the rope, toxemia, venenation, vitiation


请选择你想看的字典辞典：
单词字典翻译
poisoning查看　poisoning　在百度字典中的解释百度英翻中〔查看〕
poisoning查看　poisoning　在Google字典中的解释Google英翻中〔查看〕
poisoning查看　poisoning　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • FDA approves cemiplimab-rwlc for adjuvant treatment of . . .
    On October 8, 2025, the Food and Drug Administration approved cemiplimab-rwlc (Libtayo, Regeneron Pharmaceuticals Inc ) for the adjuvant treatment of adults with cutaneous squamous cell carcinoma
  • FDA Approves Libtayo for Immunotherapy for Adjuvant Treatment . . .
    FDA approved of Regeneron Pharmaceutical’s Libtayo (cemiplimab-rwlc)as an adjuvant treatment for adult patients with cutaneous squamous cell carcinoma (CSCC) who are at an increased risk of recurrence following surgery and radiation 1 Libtayo was reviewed by FDA under Priority Review, a method reserved for medicines representing a potential improvement in efficacy or safety in treatments of
  • Libtayo® (cemiplimab-rwlc) Approved in the U. S. as First and . . .
    The FDA evaluated Libtayo under Priority Review, which is reserved for medicines that represent potentially significant improvements in efficacy or safety in the treatment of serious conditions An additional regulatory application is also under review in the European Union, with a decision expected by the first half of 2026
  • Libtayo (cemiplimab-rwlc) FDA Approval History - Drugs. com
    Libtayo (cemiplimab-rwlc) is a programmed death receptor-1 (PD-1) blocking antibody for the treatment of cutaneous squamous cell carcinoma (CSCC), basal cell carcinoma (BCC), and non-small cell lung cancer (NSCLC)
  • label - Food and Drug Administration
    During the treatment period ranging from 8 to 19 months in 5 clinical studies, the incidence of anti-cemiplimab-rwlc antibodies in LIBTAYO-treated patients was 2% (22 1029)
  • 2025 FDA added indications to dermatologic medications
    In October 2025, the FDA approved Libtayo (cemiplimab) as a treatment for cutaneous squamous cell carcinoma that has a high risk of recurring after it has been treated with surgery and radiation
  • FDA Approves Libtayo for Adjuvant Treatment of High-Risk CSCC
    Findings showed cemiplimab reduced the risk of disease recurrence or death by 68% compared with placebo The Food and Drug Administration (FDA) has approved Libtayo ® (cemiplimab-rwlc) for the adjuvant treatment of adult patients with cutaneous squamous cell carcinoma (CSCC) at high risk of recurrence after surgery and radiation
  • FDA Approves Libtayo for Cutaneous Squamous Cell Carcinoma . . .
    The Food and Drug Administration (FDA) has approved Libtayo (cemiplimab-rwlc) for the adjuvant, or postsurgical, treatment of adults with cutaneous squamous cell carcinoma (CSCC) at high risk of recurrence after surgery and radiation, the agency has announced Effectiveness of the drug was determined in the C-POST randomized, double-blind, multicenter, placebo-controlled trial of 415 patients
  • FDA Approves Cemiplimab for Adjuvant Cutaneous Squamous Cell . . .
    The US FDA has approved the supplemental biologics license application (sBLA) for cemiplimab-rwlc (Libtayo) as adjuvant treatment in adults with high-risk cutaneous squamous cell carcinoma (CSCC) 1 The sBLA approval was based on an extensive review of data from the pivotal phase 3 C-POST study (NCT03969004) which demonstrated a statistically significant and clinically meaningful improvement
  • FDA Approves Cemiplimab (Libtayo) for Cutaneous Squamous Cell . . .
    The U S Food and Drug Administration approved adjuvant cemiplimab (Libtayo) for adults with cutaneous squamous cell carcinoma who are at a high risk for recurrence after surgery and radiation





中文字典-英文字典  2005-2009